(Q34188093)

31 July 2017

title

Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemia (English)

1 reference

31 July 2017

1 reference

Alexandros D Tselepis

1

1 reference

31 July 2017

George Hahalis

2

1 reference

31 July 2017

Constantinos C Tellis

3

1 reference

31 July 2017

Eleni C Papavasiliou

4

1 reference

31 July 2017

Panagiota T Mylona

5

1 reference

31 July 2017

Alexandra Kourakli

6

1 reference

31 July 2017

Dimitrios C Alexopoulos

7

1 reference

31 July 2017

publication date

12 July 2010

1 reference

Journal of Lipid Research

31 July 2017

published in

1 reference

31 July 2017

volume

51

1 reference

31 July 2017

issue

11

1 reference

31 July 2017

page(s)

3331-3341

1 reference

Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Lipoprotein-associated phospholipase A2 and risk of stroke

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Thalassemia intermedia: revisited

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Longitudinal study of survival and causes of death in patients with thalassemia major in Greece

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Heart failure in beta-thalassemia syndromes: a decade of progress

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

PLAC test for identification of individuals at increased risk for coronary heart disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Platelet-activating factor in plasma of patients with sickle cell disease in steady state

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Human macrophages secret platelet-activating factor acetylhydrolase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Global vasomotor dysfunction and accelerated vascular aging in beta-thalassemia major

5 July 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M007229

Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M007229

Laparoscopic surgery-induced changes in oxidative stress markers in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M007229

Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M007229

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M007229

Metabolic syndrome and type 2 diabetes: lipid and physiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M007229

Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M007229

Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M007229

Oxidative status of platelets in normal and thalassemic blood.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952574

The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties

28 October 2018

1 reference

12 December 2020

Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated

1 reference

12 December 2020

Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions

1 reference

12 December 2020

PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme

1 reference

12 December 2020

Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis

1 reference

12 December 2020

Oxidative stress is progressively enhanced with advancing stages of CKD

1 reference

12 December 2020

Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses

1 reference

12 December 2020

Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans

1 reference

12 December 2020

Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients

1 reference

12 December 2020

Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles

1 reference

12 December 2020

Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein

1 reference

12 December 2020

Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermedia

1 reference

12 December 2020

Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma

1 reference

12 December 2020

Lipoprotein-Associated Phospholipase A 2 , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions

1 reference

12 December 2020

Platelet-activating factor acetylhydrolase in human erythrocytes

1 reference

12 December 2020

Identifiers

DOI

10.1194/JLR.M007229

1 reference

31 July 2017

1 reference

31 July 2017

1 reference